Table 3.
Prevalence of sarcopenia according to different diagnosis criteria and gender.
| Sarcopenia Diagnosis | Total (n = 136) |
Men (n = 43) |
Women (n = 93) | p-Value | ||||
|---|---|---|---|---|---|---|---|---|
| EWGSOP2 | No sarcopenia | 123 | 90.44 | 35 | 81.40 | 88 | 94.62 | 0.015 * |
| Sarcopenia | 13 | 9.56 | 8 | 18.60 | 5 | 5.38 | ||
| AWGS-2019 | No sarcopenia | 118 | 86.76 | 35 | 81.40 | 83 | 89.25 | 0.209 |
| Sarcopenia | 18 | 13.24 | 8 | 18.60 | 10 | 10.75 | ||
| IWGS | No sarcopenia | 125 | 91.91 | 37 | 86.05 | 88 | 94.62 | 0.088 |
| Sarcopenia | 11 | 8.09 | 6 | 13.95 | 5 | 5.38 | ||
| MSRA-5 | No risk of sarcopenia | 42 | 30.88 | 19 | 44.19 | 23 | 24.73 | 0.022 * |
| Risk of sarcopenia | 94 | 69.12 | 24 | 55.81 | 70 | 75.27 | ||
| MSRA-7 | No risk of sarcopenia | 28 | 20.59 | 13 | 30.23 | 15 | 16.13 | 0.059 |
| Risk of sarcopenia | 108 | 79.41 | 30 | 69.77 | 78 | 83.87 | ||
Values expressed as frequencies and percentages. AWGS: Asian Working Group on Sarcopenia. EWGSOP2: Revised European Working Group of Sarcopenia in Older People. IWGS: International Working Group on Sarcopenia. MSRA: Mini Sarcopenia Risk Assessment. * p value < 0.05.